Thurein Htoo

Mr. Htoo is the Chief Executive Officer and Co-Founder of Qlaris Bio. Mr. Htoo is a biopharmaceutical strategist primarily focused in ophthalmology and rare disease. He was previously the Chief Business Officer of Qrativ. Before Qrativ, he was VP, Head of Business Development and Corporate Strategy at Novelion Therapeutics where he had helped orchestrate the merger of QLT Inc. and Aegerion Pharmaceuticals to form Novelion. Mr. Htoo has also held leadership roles encompassing business development and disease area strategy in Ophthalmology and Rare Diseases at Pfizer and at NPS Pharmaceuticals.

Mr. Htoo holds an MBA from the University of Rochester, and both an MS in Physiology and a BAS in Neurobiology and in Psychology from UC Davis.